Lawrence, Massachusetts, October 15, 2025
News Summary
Revvity Inc., a biomanufacturer, is set to lay off more than 100 employees as it consolidates operations at its Hopkinton campus. The layoffs affect its Lawrence facility, impacting 58 workers, and its South End location in Boston, with initially reported 74 layoffs now adjusted to 76. Most affected employees will be offered relocation opportunities. The company, headquartered in Waltham, has experienced financial challenges and industry pressures, leading to this significant reduction in workforce.
Lawrence, Massachusetts — Revvity Inc. is cutting more than 100 jobs in Massachusetts as it closes two area facilities and consolidates operations at its Hopkinton campus.
Key developments
Revvity Inc., a biomanufacturer, is cutting over 100 jobs as it consolidates operations into its Hopkinton headquarters. The company filed a notice with the state regarding the closure of its Lawrence manufacturing facility located at 360 Merrimack St., affecting 58 employees. This action follows a previous announcement of 76 layoffs at Revvity’s South End site on Albany Street in Boston.
A separate Worker Adjustment and Retraining Notification (WARN) filing for the Boston site reported the layoff of 74 employees, with layoffs expected to start in November 2025 and continue through December 2026. The WARN notice for the Boston facility initially estimated 74 layoffs but later adjusted to 76.
Relocation and timing
A company spokesperson said most affected employees from Lawrence and Boston will be offered relocation opportunities to Hopkinton. The Hopkinton office is located within an hour’s drive of both closed facilities, according to Google Maps.
Layoffs at the Lawrence site are anticipated to begin in December 2025, with most occurring by January 2026. Employees will receive at least two months’ written notice prior to termination, as per WARN regulations.
Who and which roles are affected
The Boston layoffs affect a range of technical and support roles. Affected roles in Boston include chemists, physicists, equipment engineers, and material handlers, all undergoing permanent layoffs with no bumping rights. The Lawrence closure affects manufacturing staff located at the 360 Merrimack St. site.
Company context and financials
Revvity is one of Massachusetts’s largest public companies, focusing on health science solutions and technologies, including translational multiomics, biomarker identification, and diagnostics. The company is headquartered in Waltham and employs around 11,000 individuals. Revvity is a spin-out of PerkinElmer Inc. and is the 35th largest public company in Massachusetts.
Financial results show mixed signals. The company’s annual report disclosed a net income of $270.38 million for 2024, down from $693.09 million in 2023, with total revenue of $2.76 billion. The second quarter of 2024 resulted in $720 million in revenue, showing some signs of promise amidst ongoing challenges. The company’s stock price peaked at $189.04 per share in 2021 but has since declined to approximately $84 per share, trailing behind the S&P 500 index. The company reported a 26% decline in stock value since the beginning of 2025, with a market capitalization of $10.64 billion. The next earnings report for the company is scheduled for October 27.
Reasons and sector trends
Revvity has faced several pressures in recent years, including unclear academic research funding, industry-specific tariffs, and new regulations affecting diagnostics volumes in China. These factors have contributed to decisions to consolidate operations. The consolidation of operations aligns with a broader trend in the biotech sector towards operational efficiency amidst economic uncertainty.
The closures may have significant implications for the biotech employment landscape in Massachusetts and could affect local economies and supply chains. The company’s consolidation to Hopkinton, combined with the timing and scope of WARN notices, will shape local labor markets and supplier relationships in the coming months.
What to expect next
- Relocation offers will be extended to many affected employees; acceptance rates and timelines are not yet disclosed.
- Layoff notices and schedules will follow WARN timelines, with at least two months’ written notice prior to termination.
- The company’s upcoming earnings report on October 27 may provide further context on financials and strategic direction.
FAQ
How many jobs is Revvity cutting?
Revvity Inc., a biomanufacturer, is cutting over 100 jobs as it consolidates operations into its Hopkinton headquarters.
Which facility did the company file a notice about?
The company filed a notice with the state regarding the closure of its Lawrence manufacturing facility located at 360 Merrimack St., affecting 58 employees.
Did Revvity announce layoffs in Boston?
This action follows a previous announcement of 76 layoffs at Revvity’s South End site on Albany Street in Boston.
What did the WARN filing for Boston report?
Revvity filed a Worker Adjustment and Retraining Notification (WARN) for its Boston facility, reporting the layoff of 74 employees, with layoffs expected to start in November 2025 and continue through December 2026.
Was the Boston WARN notice adjusted?
The WARN notice for the Boston facility initially estimated 74 layoffs but later adjusted to 76.
Will employees be offered relocation?
A spokesperson for Revvity stated that most affected employees from Lawrence and Boston will be offered relocation opportunities to Hopkinton.
How far is Hopkinton from the closed facilities?
The Hopkinton office is located within an hour’s drive of both closed facilities, according to Google Maps.
When will Lawrence layoffs begin?
Layoffs at the Lawrence site are anticipated to begin in December 2025, with most occurring by January 2026.
How much notice will employees receive?
Employees will receive at least two months’ written notice prior to termination, as per WARN regulations.
What are some company financials and background facts?
The company’s annual report disclosed a net income of $270.38 million for 2024, down from $693.09 million in 2023, with total revenue of $2.76 billion. The second quarter of 2024 resulted in $720 million in revenue, showing some signs of promise amidst ongoing challenges. The company’s stock price peaked at $189.04 per share in 2021 but has since declined to approximately $84 per share, trailing behind the S&P 500 index. The next earnings report for the company is scheduled for October 27. The company reported a 26% decline in stock value since the beginning of 2025, with a market capitalization of $10.64 billion. Revvity is one of Massachusetts’s largest public companies, focusing on health science solutions and technologies, including translational multiomics, biomarker identification, and diagnostics. The company is headquartered in Waltham and employs around 11,000 individuals. Revvity is a spin-out of PerkinElmer Inc. and is the 35th largest public company in Massachusetts.
Quick reference table
| Item | Detail |
|---|---|
| Primary location named in this report | Lawrence, Massachusetts |
| Lawrence facility address | 360 Merrimack St. |
| Employees affected at Lawrence | 58 employees |
| Boston site layoffs announced | 76 layoffs at Revvity’s South End site on Albany Street in Boston |
| Boston WARN filing reported | Layoff of 74 employees; layoffs expected to start in November 2025 and continue through December 2026 |
| Adjusted Boston layoff estimate | WARN notice initially estimated 74 layoffs but later adjusted to 76 |
| Relocation option | Most affected employees from Lawrence and Boston will be offered relocation opportunities to Hopkinton |
| Hopkinton proximity | The Hopkinton office is located within an hour’s drive of both closed facilities, according to Google Maps |
| Lawrence layoff start | Anticipated to begin in December 2025, with most occurring by January 2026 |
| Notice period | Employees will receive at least two months’ written notice prior to termination, as per WARN regulations |
| Company headquarters | Waltham |
| Employees company-wide | Around 11,000 individuals |
| 2024 net income | $270.38 million |
| 2023 net income | $693.09 million |
| Total revenue (annual) | $2.76 billion |
| Q2 2024 revenue | $720 million |
| Next earnings report | October 27 |
Deeper Dive: News & Info About This Topic
HERE Resources
Revvity to Close Boston Facility, Leading to 76 Layoffs
Boston’s Life Sciences Sector Faces Unprecedented Downturn
National Coffee Day Promotions in Boston
Massachusetts Cities Rank Among Best Places to Live
Boston Biotech Layoffs: How To Navigate Severance, Benefits, And Job Search
Boston Job Market Outlook 2025: Hiring Trends For Tech And Healthcare
Massachusetts Layoffs 2025: Guide For Affected Workers And Job Seekers
Revvity Layoffs 2025: Who Was Impacted And What To Do Next
Federal Funding Canceled for Boston Transportation Projects
Massachusetts Business Landscape Faces Disruption
Additional Resources
- Boston.com: Revvity Cuts Jobs in Massachusetts
- Patriot Ledger: Waltham-based Biomanufacturer Revvity to Lay Off More than 70 Workers
- Boston Real Estate Times: Revvity Closes Second Massachusetts Site
- Business Wire: Revvity to Hold Earnings Call
- NBC Boston: Revvity Layoffs in Boston Facility
- Wikipedia: Job Loss
- Google Search: Revvity Inc. layoffs
- Google Scholar: Revvity Biomanufacturer
- Encyclopedia Britannica: Biomanufacturer
- Google News: Revvity layoffs
Author: STAFF HERE BOSTON WRITER
The BOSTON STAFF WRITER represents the experienced team at HEREBoston.com, your go-to source for actionable local news and information in Boston, Suffolk County, and beyond. Specializing in "news you can use," we cover essential topics like product reviews for personal and business needs, local business directories, politics, real estate trends, neighborhood insights, and state news affecting the area—with deep expertise drawn from years of dedicated reporting and strong community input, including local press releases and business updates. We deliver top reporting on high-value events such as Boston Marathon, Head of the Charles Regatta, and Boston Harborfest. Our coverage extends to key organizations like the Greater Boston Chamber of Commerce and Associated Industries of Massachusetts, plus leading businesses in finance, biotech, and insurance that power the local economy such as Fidelity Investments, Biogen, and Liberty Mutual Insurance. As part of the broader HERE network, we provide comprehensive, credible insights into Massachusetts's dynamic landscape.
